XML 32 R50.htm IDEA: XBRL DOCUMENT v3.20.1
Subsequent Events (Details) - USD ($)
 1 Months Ended 3 Months Ended 12 Months Ended
Jun. 30, 2020
Jun. 30, 2020
Jun. 09, 2020
May 31, 2020
May 28, 2020
Mar. 31, 2020
Mar. 31, 2020
Apr. 30, 2020
Dec. 31, 2019
Subsequent Events (Textual)                  
Authorized common stock           31,250,000 31,250,000   250,000,000
Convertible debentures and warrants, description           The Debentures bear interest at 8% per annum payable quarterly, subject to an increase in case of an event of default as provided for therein. The Debentures are convertible into shares of Common Stock at any time following the date of issuance at the Purchasers' option at a conversion price of $1.60 per share, subject to certain adjustments. The Debentures are subject to mandatory conversion in the event the Company closes an equity offering of at least $5,000,000 resulting in the listing of the Company's common stock on a national securities exchange. The Debentures rank senior to all existing and future indebtedness of the Company and its subsidiaries, except for approximately $508,000 of outstanding senior indebtedness. The Company may prepay the Debentures at any time at a premium as provided for therein.      
Amount due upon default           130.00%      
Grant of stock options, description       The Company granted to a consultant 25,000 one-year non-qualified stock options exercisable at $2.50 per share, vesting in full upon confirmation of a pending project.          
2017 Equity Incentive Plan [Member]                  
Subsequent Events (Textual)                  
Increase in authorized shares under incentive plan 2,770,000     1,714,000          
Subsequent Event [Member]                  
Subsequent Events (Textual)                  
Authorized common stock       250,000,000          
Restricted common stock shares               90,000  
Stock options, description       In connection with the appointment, the Company granted to the consultant 26,087 five-year non-qualified options to purchase common stock at an exercise price of $2.50 per share (the "Initial Term Options"), vesting in six equal monthly installments on the last calendar day of each calendar month, with the first portion vesting on May 31, 2020, subject to serving as the Chief Financial Officer of the Company on each applicable vesting date. The vesting of the Initial Term Options is subject to acceleration upon the listing of the Company's securities on NYSE American or the Nasdaq Capital Market, or any successor of the foregoing. Additionally, the Company issued to the consultant 431,251 five-year non-qualified options to purchase common stock at an exercise price of $2.50 per share (the "Uplist Options"), vesting over a two-year period in equal quarterly installments on the last day of each calendar quarter, with the first portion vesting on the last day of the calendar quarter during which the Company's securities begin trading on NYSE American or the Nasdaq Capital Market, subject to serving as the Chief Financial Officer of the Company on each applicable vesting date.           
Granted to consultant       25,000          
Stock options exercisable       $ 2.50          
Convertible debentures and warrants, description         Purchasers a total of (i) $2,953,125 in the aggregate principal amount of 12.5% Original Issue Discount Senior Subordinated Secured Convertible Debentures (the "Debentures"), and (ii) 1,845,703 common stock purchase warrants (the "Warrants"), which represents 100% warrant coverage. The Company received a total of $2,625,000 in gross proceeds from the offering, taking into account the 12.5% original issue discount, before deducting offering expenses and commissions, including the placement agent's commission and fees of $295,000 and reimbursement of the placement agent's and lead investor's legal fees and the Company's legal fees in the aggregate amount of $100,000. The Company also agreed to issue to the placement agent, as additional compensation, 369,141 common stock purchase warrants exercisable at $2.00 per share.        
Exercise price         $ 2.00        
Paycheck Protection Program Loans [Member]                  
Subsequent Events (Textual)                  
Loans borrowed from bank           $ 398,545 $ 398,545    
Series F Preferred Stock [Member]                  
Subsequent Events (Textual)                  
Common stock issued upon conversion             138,926    
Preferred shares converted into common stock           11,114 11,114    
Series D Preferred Stock [Member] | Subsequent Event [Member]                  
Subsequent Events (Textual)                  
Preferred D stock, description     The Company sold in a private placement 1,375 units (the "Units") at a purchase price of $18.1818 per Unit, taking into account a 10% discount, each Unit consisting of (i) one share of Series D Preferred Stock, and (ii) a Warrant to purchase seven shares of common stock, subject to adjustment as provided for therein. The Series D Preferred Stock sold in the financing convert into a minimum of 17,188 shares of common stock. The Company received gross proceeds of $25,000 from the sale of the Units. The Warrants are exercisable for five years from the issuance date at an exercise price of $4.8 per share, subject to adjustment as provided for therein.            
Series D Warrants [Member] | Forecast [Member]                  
Subsequent Events (Textual)                  
Warrant outstanding 480,564 480,564              
Warrant exercise price $ 1.60 $ 1.60              
Common stock issuable upon exercise of warrant   1,441,692              
Series D Warrants [Member] | Subsequent Event [Member]                  
Subsequent Events (Textual)                  
Warrant outstanding       480,564          
Warrant exercise price       $ 1.60          
Common stock issuable upon exercise of warrant       1,441,692